David L Lowrance insider trades

Open-market stock purchases and sales by David L Lowrance, Chief Financial Officer at Savara Inc, from SEC Form 4 filings since Mar 26, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +128%.

Recent trades

DateStockTradeValue
Jun 22, 2026SVRA Savara IncSold (not open market)$119K
Jun 22, 2026SVRA Savara IncSold (not open market)$159K
Jun 22, 2026SVRA Savara IncSold (not open market)$63.2K
Jun 22, 2026SVRA Savara IncBought (not open market)—
Jun 22, 2026SVRA Savara IncSold (not open market)$330K
Jun 22, 2026SVRA Savara IncSold (not open market)$55.6K
Jun 22, 2026SVRA Savara IncSold (not open market)$294K
Jun 22, 2026SVRA Savara IncSold$2.2M
Jun 22, 2026SVRA Savara IncBought (not open market)—
Jun 22, 2026SVRA Savara IncBought (not open market)—
Jun 22, 2026SVRA Savara IncBought (not open market)—
Jun 22, 2026SVRA Savara IncBought (not open market)—
Jun 22, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncSold (not open market)$122K
Mar 18, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncSold (not open market)$47.8K
Mar 18, 2026SVRA Savara IncSold (not open market)$55.6K
Mar 18, 2026SVRA Savara IncSold (not open market)$83.3K
Mar 18, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncBought (not open market)—
Mar 18, 2026SVRA Savara IncSold (not open market)$119K
Mar 18, 2026SVRA Savara IncSold (not open market)$161K
Mar 18, 2026SVRA Savara IncBought (not open market)—

Companies traded

  • SVRA Savara Inc: 3 buys, 14 sales, last Jun 22, 2026
  • M?????? Acucela Inc: 1 sale, last Aug 18, 2014
  • CPIX Cumberland Pharmaceuticals Inc: other filings, last Apr 14, 2011

Get free alerts when David L Lowrance files a new trade →